Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
VKTX — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

20.46

Margin Of Safety %

Put/Call OI Ratio

0.2

EPS Next Q Diff

-2

EPS Last/This Y

-1.44

EPS This/Next Y

0.29

Price

34.26

Target Price

94.76

Analyst Recom

1.21

Performance Q

8.49

Upside

-276.8%

Beta

0.68

Ticker: VKTX



20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-13VKTX38.120.200.39200460
2026-07-14VKTX37.940.200.37203209
2026-07-15VKTX37.830.210.67203741
2026-07-16VKTX36.350.220.34207519
2026-07-17VKTX37.080.220.41211730
2026-07-20VKTX36.360.210.36181933
2026-07-21VKTX37.950.210.42186103
2026-07-22VKTX37.30.220.44190305
2026-07-23VKTX35.360.220.29192002
2026-07-24VKTX34.770.220.63195556
2026-07-27VKTX34.870.200.16186457
2026-07-28VKTX33.840.200.18191278
2026-07-29VKTX33.490.200.25196556
2026-07-30VKTX33.090.200.18200108
2026-07-31VKTX31.750.190.27206710
2026-08-03VKTX32.580.190.10200289
2026-08-04VKTX32.950.190.57209517
2026-08-05VKTX33.510.200.31217686
2026-08-06VKTX33.30.200.54222585
2026-08-07VKTX34.280.200.16225009
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1



20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-13VKTX38.16-100.0-84.2-4.72
2026-07-14VKTX37.97-100.0-94.1-4.72
2026-07-15VKTX37.84-100.0-94.6-4.72
2026-07-16VKTX36.40-100.0-70.2-4.72
2026-07-17VKTX37.07-100.0-110.8-4.72
2026-07-20VKTX36.38-100.0-83.5-4.72
2026-07-21VKTX37.94-100.0-127.8-4.72
2026-07-22VKTX37.30-100.0-84.8-4.72
2026-07-23VKTX35.38-100.0-59.8-4.72
2026-07-24VKTX34.77-100.0-84.3-4.72
2026-07-27VKTX34.86-100.0-98.5-4.72
2026-07-28VKTX33.84-100.0-75.6-4.72
2026-07-29VKTX33.46-100.0-88.4-4.72
2026-07-30VKTX33.11-100.0-90.0-4.72
2026-07-31VKTX31.74-70.4-68.6-4.60
2026-08-03VKTX32.58-70.4-24.8-4.60
2026-08-04VKTX32.58-70.4-24.8-4.60
2026-08-05VKTX33.53-35.0-19.1-4.64
2026-08-06VKTX33.31-35.0-3.1-4.64
2026-08-07VKTX34.26-32.9-26.0-4.63
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1



20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-13VKTX0.140.3820.83
2026-07-14VKTX0.140.3820.83
2026-07-15VKTX0.140.3820.83
2026-07-16VKTX0.140.3820.83
2026-07-17VKTX0.140.3820.83
2026-07-20VKTX0.140.2720.83
2026-07-21VKTX0.140.2720.83
2026-07-22VKTX0.140.2720.83
2026-07-23VKTX0.140.2720.83
2026-07-24VKTX0.140.2720.83
2026-07-27VKTX0.140.2620.52
2026-07-28VKTX0.140.2620.52
2026-07-29VKTX0.140.2620.52
2026-07-30VKTX-5.340.2620.52
2026-07-31VKTX-5.340.2620.52
2026-08-03VKTX-5.32-0.0020.43
2026-08-04VKTX-5.32-0.0020.46
2026-08-05VKTX-5.03-0.0020.46
2026-08-06VKTX-5.03-0.0020.46
2026-08-07VKTX-5.03-0.0020.46
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS​

0.89

Avg. EPS Est. Current Quarter

-1.08

Avg. EPS Est. Next Quarter

-1.11

Insider Transactions

-5.03

Institutional Transactions

Beta

0.68

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

5

Growth Score

19

Sentiment Score

39

Actual DrawDown %

65.5

Max Drawdown 5-Year %

-78.9

Target Price

94.76

P/E

Forward P/E

PEG

P/S

P/B

9.79

P/Free Cash Flow

EPS

-4.66

Average EPS Est. Cur. Y​

-4.63

EPS Next Y. (Est.)

-4.33

Target Price Estimates Raised

1

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.61

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.1

EBIT Estimation

-26
◆ VKTX Healthcare
$34.26
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
6/20
Pullback
21/25
Volume
9/15
Valuation
10/20
TP/AR
3/10
Options
8/10
RSI
47.9
Range 1M
27.4%
Sup Dist
4.1%
🚀
Momentum Growth
Ride accelerating trends
N/A
20 /100
WEAK
Momentum
2/25
Growth
7/30
Estimates
2/20
Inst/Vol
1/15
Options
8/10
EPS Yr
-44.1%
EPS NY
3.8%
52W%
54%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +176.6% upside
Quality
2/30
Valuation
15/30
Growth
4/25
Stability
7/10
LT Trend
3/5
Upside
+176.6%
Quality
5
Click a card to see score breakdown Full Analysis →
VKTX — P/E HistoricalBiotechnology
Viking Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 65
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. The company develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, which is in Phase II clinical trials for metabolic disorders and anemia; VK2735, a novel dual agonist of the glucagon-like peptide 1, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
VKTX

Latest News

—
Caricamento notizie per VKTX…
stock quote shares VKTX – Viking Therapeutics Inc. Stock Price stock today
news today VKTX – Viking Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch VKTX – Viking Therapeutics Inc. yahoo finance google finance
stock history VKTX – Viking Therapeutics Inc. invest stock market
stock prices VKTX premarket after hours
ticker VKTX fair value insiders trading